Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,069 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Early vascular aging in chronic kidney disease: focus on microvascular maintenance, senescence signature and potential therapeutics" [Translational Research 275 (2025) 32-47].
Arefin S, Mudrovcic N, Hobson S, Pietrocola F, Ebert T, Ward LJ, Witasp A, Hernandez L, Wennberg L, Lundgren T, Steinmetz-Späh J, Larsson K, Thorell A, Bruno S, Marengo M, Cantaluppi V, Stenvinkel P, Kublickiene K. Arefin S, et al. Among authors: larsson k. Transl Res. 2024 Dec 21;276:38. doi: 10.1016/j.trsl.2024.12.003. Online ahead of print. Transl Res. 2024. PMID: 39709821 Free article. No abstract available.
Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements.
Mouhanna P, Ståhlberg A, Andersson D, Albu-Kareem A, Elinder E, Eriksson O, Kavanagh A, Kovács A, Larsson KF, Linderholm B, Uminska M, Österlund T, Howell SJ, Ekholm M. Mouhanna P, et al. Among authors: larsson kf. Int J Cancer. 2024 Dec 18. doi: 10.1002/ijc.35292. Online ahead of print. Int J Cancer. 2024. PMID: 39692755
Early vascular aging in chronic kidney disease: focus on microvascular maintenance, senescence signature and potential therapeutics.
Arefin S, Mudrovcic N, Hobson S, Pietrocola F, Ebert T, Ward LJ, Witasp A, Hernandez L, Wennberg L, Lundgren T, Steinmetz-Späh J, Larsson K, Thorell A, Bruno S, Marengo M, Cantaluppi V, Stenvinkel P, Kublickiene K. Arefin S, et al. Among authors: larsson k. Transl Res. 2025 Jan;275:32-47. doi: 10.1016/j.trsl.2024.11.001. Epub 2024 Nov 5. Transl Res. 2025. PMID: 39510246 Free article.
Navigating the orphan medicinal product designation: Evidence requirements for gene therapies in Europe.
Palomo GM, Pose-Boirazian T, Naumann-Winter F, Costa E, Duarte DM, Kalland ME, Malikova E, Matusevicius D, Vitezic D, Larsson K, Magrelli A, Stoyanova-Beninska V, Mariz S. Palomo GM, et al. Among authors: larsson k. Mol Ther. 2024 Oct 28:S1525-0016(24)00675-0. doi: 10.1016/j.ymthe.2024.10.015. Online ahead of print. Mol Ther. 2024. PMID: 39489919 Free article.
1,069 results